These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8381248)

  • 1. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.
    van Drunen Littel-van den Hurk S; Parker MD; Massie B; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
    Vaccine; 1993; 11(1):25-35. PubMed ID: 8381248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines.
    Israel BA; Marshall RL; Letchworth GJ
    Vaccine; 1988 Aug; 6(4):349-56. PubMed ID: 2461006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.
    van Drunen Littel-van den Hurk S; Van Donkersgoed J; Kowalski J; van den Hurk JV; Harland R; Babiuk LA; Zamb TJ
    Vaccine; 1994 Nov; 12(14):1295-302. PubMed ID: 7856294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins.
    van Drunen Littel-van den Hurk S; Gifford GA; Babiuk LA
    Vaccine; 1990 Aug; 8(4):358-68. PubMed ID: 1697722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins.
    Babiuk LA; L'Italien J; van Drunen Littel-van den Hurk S; Zamb T; Lawman JP; Hughes G; Gifford GA
    Virology; 1987 Jul; 159(1):57-66. PubMed ID: 3037783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
    Gao Y; Leary TP; Eskra L; Splitter GA
    Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passively administered neutralizing monoclonal antibodies do not protect calves against bovine herpesvirus 1 infection.
    Marshall RL; Letchworth GJ
    Vaccine; 1988 Aug; 6(4):343-8. PubMed ID: 2461005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1.
    Zakhartchouk AN; Pyne C; Mutwiri GK; Papp Z; Baca-Estrada ME; Griebel P; Babiuk LA; Tikoo SK
    J Gen Virol; 1999 May; 80 ( Pt 5)():1263-1269. PubMed ID: 10355773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.
    van Drunen Littel-van den Hurk S; Parker MD; Fitzpatrick DR; Zamb TJ; van den Hurk JV; Campos M; Harland R; Babiuk LA
    J Virol; 1991 Jan; 65(1):263-71. PubMed ID: 1845887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle.
    Zhu X; Letchworth GJ
    Vaccine; 1996 Jan; 14(1):61-9. PubMed ID: 8821651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1.
    Ellis JA; Gow SP; Goji N; Jones C; Workman A; Henderson G; Rhodes C; Alaniz G; Meinert TR; Tucker CM
    J Am Vet Med Assoc; 2009 Sep; 235(5):563-72. PubMed ID: 19719449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine recombinant interleukin-2 augments immunity and resistance to bovine herpesvirus infection.
    Reddy PG; Blecha F; Minocha HC; Anderson GA; Morrill JL; Fedorka-Cray PJ; Baker PE
    Vet Immunol Immunopathol; 1989 Nov; 23(1-2):61-74. PubMed ID: 2559538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response.
    Gao Y; Daley MJ; Splitter GA
    Vaccine; 1995 Jun; 13(9):871-7. PubMed ID: 7483811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease.
    Mahan SM; Sobecki B; Johnson J; Oien NL; Meinert TR; Verhelle S; Mattern SJ; Bowersock TL; Leyh RD
    J Am Vet Med Assoc; 2016 Jun; 248(11):1280-6. PubMed ID: 27172345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells.
    Tikoo SK; Fitzpatrick DR; Babiuk LA; Zamb TJ
    J Virol; 1990 Oct; 64(10):5132-42. PubMed ID: 2168991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bovine immune responses to affinity-purified bovine herpesvirus-1 antiidiotypes and glycoproteins.
    Orten DJ; Xue W; van Drunen Littel-van den hurk S; Abdelmagid OY; Reddy DN; Campos M; Babiuk LA; Blecha F; Minocha HC
    Viral Immunol; 1993; 6(2):109-17. PubMed ID: 8216712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection.
    Reddy DN; Reddy PG; Minocha HC; Fenwick BW; Baker PE; Davis WC; Blecha F
    Lymphokine Res; 1990; 9(3):295-307. PubMed ID: 2169009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes.
    Kit M; Kit S; Little SP; Di Marchi RD; Gale C
    Vaccine; 1991 Aug; 9(8):564-72. PubMed ID: 1722936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.